Black Diamond Therapeutics (BDTX) EV/EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EV/EBITDA | ? | -0.09 | 1.03 | 1.23 | -0.53 | 1.22 | -0.53 | |
| Changes by years, y/y, % | -99% | -1 223% | +20% | -143% | -331% | |||
Black Diamond Therapeutics. EV/EBITDA
Black Diamond Therapeutics. EV/EBITDA, changes, %
Black Diamond Therapeutics (BDTX) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | 11.7 | 2.38 | 5.43 | 0.98 | -0.53 | -0.53 | |
| Changes by years, y/y, % | +998% | +108% | -382% | -273% | -105% | |||
| Changes by quarters, q/q, % | -2 158% | -80% | +128% | -82% | -154% | |||